首页> 外文期刊>BMJ Open >Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol
【24h】

Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol

机译:在使用不同的意向性治疗方法预防磨损偏倚后解释试验结果:一项元流行病学研究方案

获取原文
           

摘要

Introduction When participants drop out of randomised clinical trials, as frequently happens, the intention-to-treat (ITT) principle does not apply, potentially leading to attrition bias. Data lost from patient dropout/lack of follow-up are statistically addressed by imputing, a procedure prone to bias. Deviations from the original definition of ITT are referred to as modified intention-to-treat (mITT). As yet, the impact of the potential bias associated with mITT has not been assessed. Our objective is to investigate potential bias and disadvantages of performing mITT and evaluate possible concerns when executing different mITT approaches in meta-analyses. Methods and analysis Using meta-epidemiology on randomised trials considered less prone to bias (ie, good internal validity) and assessing biological or targeted agents in patients with rheumatoid arthritis, we will meta-analyse data from 10 biological and targeted drugs based on collections of trials that would correspond to 10 individual meta-analyses. Ethics and dissemination This study will enhance transparency for evaluating mITT treatment effects described in meta-analyses. The intended audience will include healthcare researchers, policymakers and clinicians. Results of the study will be disseminated by peer-review publication. Protocol registration In PROSPERO CRD42013006702, 11. December 2013.
机译:简介当参与者退出随机临床试验时(如经常发生的情况),意向性治疗(ITT)原则将不适用,可能导致减员偏倚。从患者辍学/缺乏随访中丢失的数据可以通过估算来统计处理,该过程易于产生偏差。与ITT原始定义的差异称为修改后的意向治疗(mITT)。迄今为止,尚未评估与mITT相关的潜在偏见的影响。我们的目标是调查执行mITT的潜在偏见和缺点,并在荟萃分析中执行不同的mITT方法时评估可能的担忧。方法和分析在被认为不易产生偏倚(即良好的内部有效性)的随机试验中使用亚流行病学,并评估类风湿性关节炎患者的生物学或靶向药物,我们将基于10种生物学和靶向药物的荟萃分析数据与10项荟萃分析相对应的试验。伦理与传播这项研究将提高在荟萃分析中评估mITT治疗效果的透明度。预定的受众将包括医疗保健研究人员,政策制定者和临床医生。研究结果将通过同行评审发布。协议注册于PROSPERO CRD42013006702,2013年12月11日。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号